Hood River Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$36.8M Sell
2025
Q2
$25.6M Buy
2025
Q1
$29.3M Buy
2024
Q4
$43.5M Buy
2024
Q3
$42.7M Buy
2024
Q2
$18.4M Buy